Catharina Hagerling
11 – 20 of 28
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Differential Activation of Immune Effector Processes in Mature Compared to Immature Sacrococcygeal Teratomas
(
- Contribution to journal › Article
-
Mark
Cellular architecture of human brain metastases
(
- Contribution to journal › Article
-
Mark
The immune cell atlas of human neuroblastoma
(
- Contribution to journal › Article
- 2021
-
Mark
High levels of expression of cartilage oligomeric matrix protein in lymph node metastases in breast cancer are associated with reduced survival
(
- Contribution to journal › Article
-
Mark
Regulatory T lymphocyte infiltration in metastatic breast cancer—an independent prognostic factor that changes with tumor progression
(
- Contribution to journal › Article
-
Mark
Variability in Breast Cancer Biomarker Assessment and the Effect on Oncological Treatment Decisions: A Nationwide 5-Year Population-Based Study
(
- Contribution to journal › Article
- 2020
-
Mark
LGR5 in breast cancer and ductal carcinoma in situ : a diagnostic and prognostic biomarker and a therapeutic target
(
- Contribution to journal › Article
-
Mark
Inflammatory macrophage derived TNFα downregulates estrogen receptor α via FOXO3a inactivation in human breast cancer cells
(
- Contribution to journal › Article
-
Mark
Complement inhibitor factor H expressed by breast cancer cells differentiates CD14+ human monocytes into immunosuppressive macrophages
(
- Contribution to journal › Article
- 2019
-
Mark
Immune effector monocyte–neutrophil cooperation induced by the primary tumor prevents metastatic progression of breast cancer
2019) In Proceedings of the National Academy of Sciences of the United States of America 116(43). p.21704-21714(
- Contribution to journal › Article